Bioactive Peptides: Potential Impact on the Treatment of Gastrointestinal Cancers Publisher Pubmed



Pourali G¹ ; Kazemi D² ; Pourali R³ ; Rahmani N¹ ; Razzaghi E² ; Maftooh M¹ ; Fiuji H^{1, 4, 5} ; Ghorbani E⁴ ; Khazaei M^{1, 4} ; Ferns GA⁶ ; Hassanian SM^{1, 4} ; Avan A^{1, 4, 5} Show Affiliations
Source: Current Pharmaceutical Design Published:2023

Abstract

We have reviewed the potential use of bioactive peptides in the treatment of gastrointestinal (GI) malignancies, which are a significant cause of morbidity and mortality globally. Conventional therapies, such as surgery, chemotherapy, and radiotherapy, are associated with numerous side effects that may lead to longterm complications. Bioactive peptides are short-chain amino acids that can be extracted from natural sources or synthesized, and they have various potential health benefits, including anti-inflammatory, anti-hypertensive, antioxidant, antimicrobial, and anti-cancer properties. Bioactive peptides can be acquired from animal or plant sources, and can be classified based on their function, such as ACE-inhibiting, antimicrobial, and electrolyte-regulating peptides. Recent studies have demonstrated the promising role of bioactive peptides in tumor suppression, especially when combined with conventional therapies. In this study, we have reviewed the beneficial properties of bioactive peptides and their role in suppressing tumor activity. The mechanisms of bioactive peptides in tumor suppression are discussed. We have further reviewed the findings of preclinical and clinical studies that have investigated the application of bioactive peptides in the treatment of GI cancers. This review highlights the potential use of bioactive peptides as a promising treatment method for GI malignancies to increase the quality of life of GI cancer patients. © 2023 Bentham Science Publishers.